The LIM-Only Protein FHL2 Reduces Vascular Lesion Formation Involving Inhibition of Proliferation and Migration of Smooth Muscle Cells by Karakula K. et al.

Life Sciences Research

In this study, the authors investigated the modulatory effects of LIM-only protein FHL2/DRA/SLIM3 in phenotypic changes of Smooth Muscles Cells (SMC) in SMC-rich lesion formation.
They have found that FHL2 regulates SMC’s functions during vascular proliferative diseases by modulating Cyclin D1 expression via ERK 1/2 signaling pathway.

Congratulations to the authors, who turned to tebu-bio’s range of products when selecting their growth factors to culture aortic SMC for in vitro scratch-wound and migration assays.

Want to know more?

Source: Karakula K. et al. “The LIM-Only Protein FHL2 Reduces Vascular Lesion Formation Involving Inhibition of Proliferation and Migration of Smooth Muscle Cells” (2014) 9(4): e94931. doi:10.1371/journal.pone.0094931

Related research products:

Oris Cell Migration Assay Video

Philippe Fixe, PhD
Written by Philippe Fixe, PhD
Philippe Fixe is Marketing Director at tebu-bio, passionate about innovation and R&D in Life sciences, Biotechnology, Medical research, Drug discovery, and also a keen photographer.